|

Tenecteplase (1/3 systemic weight based dose) Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: TNKase

Pipeline

Phase 3: 1

Top Sponsors

  • University of Sydney1

Indications

Other1 trial

A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.